Preclinical Assessment of a Compliance Matched Biopolymer Vascular Graft

顺应性匹配的生物聚合物血管移植物的临床前评估

基本信息

项目摘要

PROJECT ABSTRACT Cardiovascular diseases represent the leading cause of death worldwide and are currently responsible for 32% of all reported deaths before the start of the COVID-19 pandemic. The increase in cardiovascular disease prominence has placed increasing levels of demand for cardiac bypass grafting (CABG), which is now the most common cardiac surgery in the world. Despite CABG interventions with autologous tissues are viewed as one of the most effective treatment options, their failure of rate remains as high as 42.8%, with only 50% to 60% maintaining patency after 10 years. Vascular engineering research has sought to develop tissue engineered vascular grafts (TEVG) in the form of acellular or cellularized constructs as an alternative solution. Despite decades of research advancements, very few TEVGs have reached clinical studies, and there are no clinically approved TEVGs currently in use. Here we seek to advance our understanding of how TEVGs are infiltrated by the host’s cells when stimulated by three different isoforms of the protein Transforming Growth Factor Beta, and the impact this treatment can have on cellular remodeling of the TEVGs. Aim 1: Investigate native vascular tissue stromal cell migration onto and proliferation within a TEVG that is compliance matched and TGFβ isoform loaded in a 3D culture system. We will test the hypothesis that compliance matched TEVGs containing TGFβ2 loaded microparticles can modulate the rates of explanted native vascular tissue cellular migration and proliferation onto an adjoined TEVG at significantly higher levels than delivery of two alternative TGFβ isoforms utilizing a 3D culture system. Native rat arterial tissues will be canulated and placed into the 3D culture system adjoined to a compliance matched TEVGs. The acellular TEVGs will initially be manufactured to carry PLGA microparticles (MPs) loaded with TGFβ isoforms (TGFβ-1, -2, -3, respectively) to provide a controlled release of TGFβ from the intimal layer of the TEVGs. We will assess early and late term cellular migration and proliferation onto the TEVG scaffolds as a function of culture time and TGFβ isoform release across a selection of release rates and dosages. We will quantify these results using multiphoton intravital imaging of the specialized 3D biaxial TEVG culture system. Aim 2: Assess the cellular remodeling of the compliance matched TGFβ isoform loaded TEVGs through intravital 2-photon imaging. To investigate the subsequent ECM remodeling of the compliance matched TEVGs carrying TGFβ isoform loaded MPs in 3D culture, we will utilize intravital imaging of explanted native rat abdominal aortas adjoined to TEVGs in culture as before. In this supplemental aim, we will utilize the 2-photon imaging system to quantify ECM remodeling via collagen/elastin content though second harmonic generation (SHG, collagens) and 2-photon excited fluorescence (2PEF, elastin) signals. We will assess scaffold matrix remodeling by relative SHG and 2PEF levels as a function of culture time and the respective TGFβ isoform delivered. Aim 3: Investigate the impact of progressive biaxial biomechanical stimulation of the TGFβ isoform loaded TEVGs by assessing cellular migration, proliferation, and remodeling of the TEVGs by infiltrating stromal cells. We will utilize another feature of our custom-built bioreactors (biaxial biomechanical loading) to impose controlled pulsatile pressures and axial stretches upon the TEVGs to determine if this biomechanical stimulation synergizes with the TGFβ isoform delivery to enhance cellular activity. As before, the native rat aorta tissues will be adjoined to the TEVGs, this time exposed to a selection of progressive biaxial biomechanical conditioning scenarios. Cellular migration, proliferation, and remodeling of the TEVGs will be assessed with our intravital 2-photon intravital imaging system as before, and TEVG remodeling will be determined by the relative SHG and SPEF signal generation at various locations throughout the scaffolds as before. We will assess these measures as a function of culture time and levels of biaxial biomechanical loading in combination with TGFβ isoform delivery to determine how each uniquely impacts cellular remodeling outcomes.
项目摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jonathan Pieter Vande Geest其他文献

Characterizing Bruch's membrane: State-of-the-art imaging, computational segmentation, and biologic models in retinal disease and health
布鲁赫膜的特征描述:视网膜疾病与健康状态中的先进成像、计算分割及生物学模型
  • DOI:
    10.1016/j.preteyeres.2025.101358
  • 发表时间:
    2025-05-01
  • 期刊:
  • 影响因子:
    14.700
  • 作者:
    Joshua Ong;Amrish Selvam;Matthew Driban;Arman Zarnegar;Susana Isabel Morgado Mendes Antunes Da Silva;Jincy Joy;Ethan A. Rossi;Jonathan Pieter Vande Geest;José-Alain Sahel;Jay Chhablani
  • 通讯作者:
    Jay Chhablani

Jonathan Pieter Vande Geest的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jonathan Pieter Vande Geest', 18)}}的其他基金

Biocarpet: The Next Generation Endovascular Device for Peripheral Arterial Disease
Biocarpet:治疗外周动脉疾病的下一代血管内装置
  • 批准号:
    10744597
  • 财政年份:
    2023
  • 资助金额:
    $ 12.51万
  • 项目类别:
Preclinical Assessment of a Compliance Matched Biopolymer Vascular Graft
顺应性匹配的生物聚合物血管移植物的临床前评估
  • 批准号:
    10366911
  • 财政年份:
    2021
  • 资助金额:
    $ 12.51万
  • 项目类别:
Preclinical Assessment of a Compliance Matched Biopolymer Vascular Graft
顺应性匹配的生物聚合物血管移植物的临床前评估
  • 批准号:
    10540762
  • 财政年份:
    2021
  • 资助金额:
    $ 12.51万
  • 项目类别:
Extracelluar Matrix Organization and Biomechanics of the Lamina Cribrosa and Peripapillary Sclera in Populations at High Risk for Primary Open Angle Glaucoma
原发性开角型青光眼高危人群筛板和视乳头周围巩膜的细胞外基质组织和生物力学
  • 批准号:
    9293031
  • 财政年份:
    2016
  • 资助金额:
    $ 12.51万
  • 项目类别:
Development of a Microstructurally Inspired and Compliance Matched Tissue Enginee
开发受微观结构启发且顺应性匹配的组织工程
  • 批准号:
    8444206
  • 财政年份:
    2013
  • 资助金额:
    $ 12.51万
  • 项目类别:
Development of a Microstructurally Inspired and Compliance Matched Tissue Enginee
开发受微观结构启发且顺应性匹配的组织工程
  • 批准号:
    8603278
  • 财政年份:
    2013
  • 资助金额:
    $ 12.51万
  • 项目类别:
Extracelluar Matrix Organization and Biomechanics of the Lamina Cribrosa and Peri
筛板和周周的细胞外基质组织和生物力学
  • 批准号:
    8188325
  • 财政年份:
    2011
  • 资助金额:
    $ 12.51万
  • 项目类别:
Extracelluar Matrix Organization and Biomechanics of the Lamina Cribrosa and Peri
筛板和周周的细胞外基质组织和生物力学
  • 批准号:
    8703108
  • 财政年份:
    2011
  • 资助金额:
    $ 12.51万
  • 项目类别:
Extracelluar Matrix Organization and Biomechanics of the Lamina Cribrosa and Peri
筛板和周周的细胞外基质组织和生物力学
  • 批准号:
    8304189
  • 财政年份:
    2011
  • 资助金额:
    $ 12.51万
  • 项目类别:
Extracelluar Matrix Organization and Biomechanics of the Lamina Cribrosa and Peri
筛板和周周的细胞外基质组织和生物力学
  • 批准号:
    8509699
  • 财政年份:
    2011
  • 资助金额:
    $ 12.51万
  • 项目类别:

相似海外基金

Un/kindness, shame & resistance: the care of inpatients in NHS adult acute mental health units and how it might be improved
Un/善良,羞耻
  • 批准号:
    2885806
  • 财政年份:
    2023
  • 资助金额:
    $ 12.51万
  • 项目类别:
    Studentship
Post-Acute Care Transitions for Older Adult Medicare Beneficiaries with Serious Mental Illness
患有严重精神疾病的老年医疗保险受益人的急性后护理过渡
  • 批准号:
    10772386
  • 财政年份:
    2023
  • 资助金额:
    $ 12.51万
  • 项目类别:
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
通过 CAR-T 细胞疗法为加拿大护理标准铺平道路:CD19 CAR-T 治疗复发/难治性成人急性淋巴细胞白血病的 II 期试验 (CLIC-01A)
  • 批准号:
    474619
  • 财政年份:
    2022
  • 资助金额:
    $ 12.51万
  • 项目类别:
    Operating Grants
Investigating the impact acute inhalation of cannabis with a high content of delta-9-tetrahydrocannabinol has on myelination and microglia in adult and aged mice
研究急性吸入高含量 delta-9-四氢大麻酚的大麻对成年和老年小鼠髓鞘形成和小胶质细胞的影响
  • 批准号:
    485965
  • 财政年份:
    2022
  • 资助金额:
    $ 12.51万
  • 项目类别:
    Studentship Programs
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
通过 CAR-T 细胞疗法为加拿大护理标准铺平道路:CD19 CAR-T 治疗复发/难治性成人急性淋巴细胞白血病的 II 期试验 (CLIC-01A)
  • 批准号:
    466358
  • 财政年份:
    2022
  • 资助金额:
    $ 12.51万
  • 项目类别:
    Operating Grants
Metabolomics for prediction of cisplatin mediated acute kidney injury: a Canadian multi-centre adult and pediatric study
预测顺铂介导的急性肾损伤的代谢组学:加拿大多中心成人和儿童研究
  • 批准号:
    402040
  • 财政年份:
    2019
  • 资助金额:
    $ 12.51万
  • 项目类别:
    Operating Grants
Study of pathogenic mechanism of age-dependent chromosome translocation in adult acute lymphoblastic leukemia
成人急性淋巴细胞白血病年龄依赖性染色体易位发病机制研究
  • 批准号:
    18K16103
  • 财政年份:
    2018
  • 资助金额:
    $ 12.51万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Causal effect of time-varying driving pressures on mortality in mechanically ventilated, adult patients with acute respiratory distress syndrome
时变驱动压力对机械通气成年急性呼吸窘迫综合征患者死亡率的因果影响
  • 批准号:
    377313
  • 财政年份:
    2017
  • 资助金额:
    $ 12.51万
  • 项目类别:
    Studentship Programs
Role of SETBP1 in adult Ph+ acute lymphoblastic leukemia
SETBP1 在成人 Ph 急性淋巴细胞白血病中的作用
  • 批准号:
    9315111
  • 财政年份:
    2016
  • 资助金额:
    $ 12.51万
  • 项目类别:
Acute Inhibition of Adult-born Granule Cells and its Effect on Antidepressant Act
成体颗粒细胞的急性抑制及其抗抑郁作用
  • 批准号:
    8734273
  • 财政年份:
    2013
  • 资助金额:
    $ 12.51万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了